CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company
4D Molecular Therapeutics, Inc.
Sign in to watch- Ticker
- FDMT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473506994
- Phone
- 5105052680
- Business address
- 5858 HORTON STREET #455, EMERYVILLE, CA, 94608
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
- 8-K Event Other events
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.59 ($17,315)
- 144 Insider Sale of Securities
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 8-K Event Material agreement
- 4 Planned sale Chief Legal Officer sold 2,678 shares at $12.00 ($32,136)
- 144 Insider Sale of Securities
- 4 Planned sale Chief Legal Officer sold 1,635 shares at $10.17 ($16,628)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale Chief Legal Officer sold 2,408 shares at $10.00 ($24,080)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change
- 4 Planned sale Chief Legal Officer sold 2,407 shares at $8.00 ($19,256)
- 144 Insider Sale of Securities
Page 5 of 23 · 441 filings